HighMark Wealth Management »

Keros Therapeutics shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.0k 75 66.20
2023-12-31 $3.0k 75 39.76
2023-09-30 $2.4k 75 31.88
2023-06-30 $3.0k 75 40.19
2021-09-30 $3.0k 148 20.27

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p Us Vlu (IUSV)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
Wells Fargo & Company (WFC)
Performant Finl (PFMT)
Eli Lilly & Co. (LLY)
Ishares Tr S&p 500 Val Etf (IVE)
Microsoft Corporation (MSFT)
Us Bancorp Del Com New (USB)
Paragon 28 (FNA)
Tela Bio (TELA)

View all positions for HighMark Wealth Management

Top funds holding Keros Therapeutics

Vanguard Group
OrbiMed Advisors
Braidwell
Darwin Global Management
T. Rowe Price Associates
Candriam Luxembourg S.C.A.
Citadel Advisors
Franklin Resources
ADAR1 Capital Management
Eventide Asset Management
Millennium Management
Deutsche Bank Aktiengesellschaft
Opaleye Management
Blue Owl Capital Holdings
Nantahala Capital Management

View all funds holding Keros Therapeutics